Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Interest & Investment Income (2016 - 2026)

OptimizeRx's Interest & Investment Income history spans 13 years, with the latest figure at $84000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 14.29% to $84000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $353000.0, a 6.65% increase, with the full-year FY2025 number at $353000.0, up 78.05% from a year prior.
  • Interest & Investment Income hit $84000.0 in Q4 2025 for OptimizeRx, down from $91000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for OPRX hit a ceiling of $721000.0 in Q2 2023 and a floor of $931.0 in Q1 2021.
  • Historically, Interest & Investment Income has averaged $180811.1 across 4 years, with a median of $90500.0 in 2025.
  • Biggest five-year swings in Interest & Investment Income: crashed 98.32% in 2021 and later skyrocketed 340.0% in 2025.
  • Tracing OPRX's Interest & Investment Income over 4 years: stood at $2382.0 in 2021, then skyrocketed by 4853.82% to $118000.0 in 2023, then dropped by 16.95% to $98000.0 in 2024, then dropped by 14.29% to $84000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for OPRX at $84000.0 in Q4 2025, $91000.0 in Q3 2025, and $90000.0 in Q2 2025.